Skip to content
Monday, June 29, 2026
  • Coons released from hospital after car crash caused minor injuries
  • Inside Serena Williams' return to tennis
  • Tillis has 'positive predisposition' toward Blanche's confirmation
  • The data center is suddenly suspect. Can Big Tech fix it?
https://ukusanews.com/

UK & USA NEWS

Newsletter
Random News
  • Poltics
  • Sports
  • Entertainment
  • Business
  • Health
  • Tech
  • Biography
  • World
  • Coons released from hospital after car crash caused minor injuries
  • Inside Serena Williams' return to tennis
  • Tillis has 'positive predisposition' toward Blanche's confirmation
  • The data center is suddenly suspect. Can Big Tech fix it?
https://ukusanews.com/

UK & USA NEWS

Newsletter
Random News
  • Poltics
  • Sports
  • Entertainment
  • Business
  • Health
  • Tech
  • Biography
  • World
Headlines
  • Coons released from hospital after car crash caused minor injuries

    6 minutes ago
  • Inside Serena Williams' return to tennis

    60 minutes ago
  • Tillis has 'positive predisposition' toward Blanche's confirmation

    1 hour ago
  • The data center is suddenly suspect. Can Big Tech fix it?

    2 hours ago
  • ⚽ World Cup overreactions: Sizing up USMNT

    2 hours ago
  • Trump: Reflecting Pool will be drained after July 4; algae 'criminally made'

    2 hours ago
  • Walsh tops Douglass' 50m freestyle world record

    3 hours ago
  • Trump warns likely next DC mayor against 'communist' policies

    3 hours ago
  • California law targeting loud streaming ads takes effect on July 1

    3 hours ago
  • USMNT squad is full of leaders for World Cup knock…

    4 hours ago
  • Home
  • Novo Nordisk A/S (B Shares) ADRhedged

Novo Nordisk A/S (B Shares) ADRhedged

  • Business

Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India

Sagar3 months ago04 mins

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The market share of India’s most popular weight‑loss drugmaker, Eli Lilly, slipped in March, while rival Novo Nordisk held steady even as Indian generic drugmakers flooded the market with lower‑priced copies. Eli Lilly’s Indian market share in the GLP‑1 category of…

Read More
  • Business

FDA approves first GLP-1 pill for obesity from Novo Nordisk

Sagar6 months ago02 mins

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Novo Nordisk, a landmark decision that health experts say could…

Read More

Recent Posts

  • Coons released from hospital after car crash caused minor injuries
  • Inside Serena Williams' return to tennis
  • Tillis has 'positive predisposition' toward Blanche's confirmation
  • The data center is suddenly suspect. Can Big Tech fix it?
  • ⚽ World Cup overreactions: Sizing up USMNT

Recent Comments

  1. Visit This Link on Trump Applauds Massive Russia-Ukraine Prisoner Swap, Hints at ‘Something Big’ in Peace Talks
  2. Buy SEO Backlinks on Trump Applauds Massive Russia-Ukraine Prisoner Swap, Hints at ‘Something Big’ in Peace Talks
  3. Birkin Hotsell Yellow Bag on Trump Applauds Massive Russia-Ukraine Prisoner Swap, Hints at ‘Something Big’ in Peace Talks
  4. scar removal treatment on LA Riots: Can Trump Send in the National Guard? Here’s What the Insurrection Act Says
  5. affordable insurance coverage on Russia-Ukraine War: Is a Ceasefire Near? Trump Plans to Call Putin and Zelensky

Archives

  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025

Categories

  • Biography
  • Business
  • Entertainment
  • Health
  • Poltics
  • Sports
  • Tech
  • World
Copyright [2026] | Powered by ukusanews.com Powered By BlazeThemes.
  • About Us
  • Contect Us
  • Fact checking Policy
  • DNAPA Code of Ethics
  • Correction Policy
  • Privacy Policy